Gérard M. London

Active 1973–2024

137
Papers
35,452
Citations
101
h-index
136
i10-index

Citations

Citations per year for Gérard M. London1973: 2 citations1975: 1 citations1976: 1 citations1978: 1 citations1979: 1 citations1981: 4 citations1982: 2 citations1983: 3 citations1985: 2 citations1986: 2 citations1987: 6 citations1988: 7 citations1989: 8 citations1990: 11 citations1991: 11 citations1992: 12 citations1993: 21 citations1994: 25 citations1995: 34 citations1996: 22 citations1997: 55 citations1998: 50 citations1999: 81 citations2000: 133 citations2001: 241 citations2002: 333 citations2003: 339 citations2004: 362 citations2005: 430 citations2006: 381 citations2007: 355 citations2008: 336 citations2009: 307 citations2010: 278 citations2011: 237 citations2012: 282 citations2013: 216 citations2014: 196 citations2015: 202 citations2016: 150 citations2017: 199 citations2018: 141 citations2019: 612 citations2020: 688 citations2021: 559 citations2022: 387 citations2023: 349 citations2024: 438 citations2025: 173 citations2026: 11 citations1974: no citations, so this year is not shown1977: no citations, so this year is not shown1980: no citations, so this year is not shown1984: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,880 citing papers, 20.1% of this breakdownUnited Kingdom: 769 citing papers, 8.2% of this breakdownFrance: 603 citing papers, 6.5% of this breakdownChina: 524 citing papers, 5.6% of this breakdownGermany: 514 citing papers, 5.5% of this breakdownItaly: 502 citing papers, 5.4% of this breakdownJapan: 391 citing papers, 4.2% of this breakdownAustralia: 373 citing papers, 4% of this breakdownNetherlands: 359 citing papers, 3.8% of this breakdownCanada: 323 citing papers, 3.5% of this breakdownSpain: 308 citing papers, 3.3% of this breakdownGreece: 232 citing papers, 2.5% of this breakdown
0%20.1%Other 27.4%

Fields

  • Medicine83.8%
  • Biochemistry, Genetics and Molecular Biology8%
  • Immunology and Microbiology1.9%
  • Engineering1.8%
  • Nursing1.8%
  • Health Professions1.1%
  • Other1.6%

Topics

  • Cardiovascular Health and Disease Prevention10.1%
  • Parathyroid Disorders and Treatments7.2%
  • Dialysis and Renal Disease Management6.6%
  • Blood Pressure and Hypertension Studies6%
  • Chronic Kidney Disease and Diabetes2.6%
  • Cardiovascular Function and Risk Factors2.6%
  • Other64.9%

Coauthors

All papers

Open in search
  1. Chronic Kidney Disease and Coronary Artery Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Krista L. Lentine, Kevin W. Lobdell, Charmaine E. Lok, Gérard M. London, Jolanta Małyszko, Patrick B. Mark, Mohamed Marwan, Yuxin Nie, Patrick S. Parfrey, Roberto Pecoits‐Filho, Helen Pilmore, Wajeh Y. Qunibi, Paolo Raggi, Marcello Rattazzi, Patrick Rossignol, Josiah Ruturi, Charumathi Sabanayagam, Catherine M. Shanahan, Gautam R. Shroff, Rukshana Shroff, Angela C Webster, Daniel E. Weiner, Simon Winther, Alexander C. Wiseman, Anthony Yip, Alexander Zarbock - Journal of the American College of Cardiology 2019 cited by 720

  2. Interaction Between Hypertension and Arterial Stiffness

    Authors: , , , , , , , , , , , - Hypertension 2018 cited by 308

  3. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality

    Authors: - Nephrology Dialysis Transplantation 2003 cited by 1,857

  4. Lipid management in patients with chronic kidney disease

    Authors: , , , , , , , , , , , , , , , - Nature Reviews Nephrology 2018 cited by 275

  5. Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure

    Authors: , , , , , , , , , , , , - The Lancet 2014 cited by 434

  6. SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA

    Authors: , , , , , , , , , , , , , , , , , - Nephrology Dialysis Transplantation 2019 cited by 204

  7. Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nephrology Dialysis Transplantation 2013 cited by 472

  8. Impact of Aortic Stiffness on Survival in End-Stage Renal Disease

    Authors: , , , , , - Circulation 1999 cited by 2,137

  9. Arterial Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal Disease

    Authors: , , , , - Hypertension 2001 cited by 1,413

  10. Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association–European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH)*

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nephrology Dialysis Transplantation 2017 cited by 226

  11. Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis

    Authors: , , , , , , , , , , , , , , - Circulation 2015 cited by 304

  12. Carotid Stiffness Is Associated With Incident Stroke

    Authors: , , , , , , , , , , - Journal of the American College of Cardiology 2015 cited by 217

  13. Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis

    Authors: , , , , , , , , , , , , , - Journal of the American Society of Nephrology 2014 cited by 210

  14. Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Krista L. Lentine, Kevin W. Lobdell, Charmaine E. Lok, Gérard M. London, Jolanta Małyszko, Patrick B. Mark, Mohamed Marwan, Yuxin Nie, Patrick S. Parfrey, Roberto Pecoits‐Filho, Helen Pilmore, Wajeh Y. Qunibi, Paolo Raggi, Marcello Rattazzi, Patrick Rossignol, Josiah Ruturi, Charumathi Sabanayagam, Catherine M. Shanahan, Gautam R. Shroff, Rukshana Shroff, Angela C Webster, Daniel E. Weiner, Simon Winther, Alexander C. Wiseman, Anthony Yip, Alexander Zarbock - Kidney International 2019 cited by 143

  15. Aortic Pulse Wave Velocity as a Marker of Cardiovascular Risk in Hypertensive Patients

    Authors: , , , , - Hypertension 1999 cited by 1,494

  16. The Agreement between Auscultation and Lung Ultrasound in Hemodialysis Patients: The LUST Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rocco Tripepi, Francesca Mallamaci, Giovanni Tripepi, Eugenio Picano, Gérard M. London, Carmine Zoccali - Clinical Journal of the American Society of Nephrology 2016 cited by 192

  17. SPARTE Study: Normalization of Arterial Stiffness and Cardiovascular Events in Patients With Hypertension at Medium to Very High Risk

    Authors: , , , , , , , , , , , , , , , , , , , , - Hypertension 2021 cited by 115

  18. Serum phosphate is associated with increased risk of bone fragility fractures in haemodialysis patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , R Cuvelier, C M De Mouscron, Max Dratwa, Chu Brugmann, Christian Tielemans, F. Dehout, Pierre Claus, A. Dhondt, B Jeren-Strujić, Marijana Gulin, Valentina Ćorić-Martinović, Draško Pavlović, Jana Smržová, Pavlikova, Valkovsky, Zahradnik, Vladimı́r Teplan, Pavukova, Nemocnice Poliklinikou, Dialyzacni Stredisko, Moucka Nemocnice, Overlæge Kjeld Otte, Fredericia Sygehus, James Heaf, Overlæge Henning Danielsen, Viborg Sygehus, Mari Kolunen, L L Markku Asola, Philit Jean-Baptiste, Philippe Nicoud, François-Louis Maurice, Mohamed Brahim Bounab, Philippe Bertocchio, Guillaume Jean, Bony Chantal, Pierre Grimal, J. Gaultier, Alex Mouneimne, Brignon, Dupuy, Jean-Paul Jaulin, Pablo Ureña, Marc Pocheville, Valérie Masson, Marc Uzan, Dominique Besnier, M Labeeuw, Głowacki, Cattanéo, Bois Guillaume, Ducloux Didier, Bouchouareb, Petitjean Philippe, Dahmane Djamel, A N G Kim-Seng, Saveanu, Gérard M. London, Bouali Boussad, François-Pascal Wambergue, J.F. de Frémont, Michel, P Giraud, Jean-Paul Eche, Bernard S. López, Catherine Delcroix, Duchet, Ghandour Majdalani, Guy, Hadj, Marie-Paule Guillodo and 280 more - Nephrology Dialysis Transplantation 2023 cited by 33

  19. Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study

    Authors: , , , , , , , , , , , , , , , - Nephrology Dialysis Transplantation 2015 cited by 197

  20. Arterial stiffening and vascular calcifications in end‐stage renal disease

    Authors: , , , - Nephrology Dialysis Transplantation 2000 cited by 996

  21. Pathophysiology of anaemia: focus on the heart and blood vessels

    Authors: , , , , - Nephrology Dialysis Transplantation 2000 cited by 372

  22. Arterial Stiffness in the Heart Disease of CKD

    Authors: , , , , , , , , , - Journal of the American Society of Nephrology 2019 cited by 212

  23. The double challenge of resistant hypertension and chronic kidney disease

    Authors: , , , , , , , , , , , , , , , , , - The Lancet 2015 cited by 184

  24. Pulmonary Hypertension in CKD

    Authors: , , , , , , , , , , , , , , , , , - American Journal of Kidney Diseases 2012 cited by 180